Advances in the treatment of tuberculosis.
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D013828:Thioacetazone / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*; D014388:Tuberculosis, Lymph Node / Q000188:drug therapy; D014390:Tuberculosis, Meningeal / Q000188:drug therapy; D014391:Tuberculosis, Miliary / Q000188:drug therapy; D014394:Tuberculosis, Osteoarticular / Q000188:drug therapy; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014401:Tuberculosis, Urogenital / Q000188:drug therapy
D000636:Aminosalicylic Acids; D011718:Pyrazinamide; D004977:Ethambutol; D013828:Thioacetazone; D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin